FIELD: biotechnology.
SUBSTANCE: present invention relates to biotechnology. According to this invention, a nucleotide sequence, in which base constituent elements thereof are modified, and a specific combination of such sequences are useful in compositions for effectively treating diseases associated with human papillomavirus (HPV) infection by strongly inhibiting the expression of E6/E7 HPV type 18 gene.
EFFECT: compositions for preventing or treating diseases associated with HPV are proposed.
6 cl, 8 dwg, 4 tbl, 1 ex
Title | Year | Author | Number |
---|---|---|---|
COMPOSITION FOR TREATMENT OF CANCER ASSOCIATED WITH HPV INFECTION | 2013 |
|
RU2636003C2 |
VECTORS FOR MULTIPLE GENE EXPRESSION | 2008 |
|
RU2462513C2 |
NUCLEOTIDE SEQUENCE EXPRESSING ANCHOR PROTEIN OF EXOSOMES FOR USE AS VACCINE | 2017 |
|
RU2761642C2 |
IMMUNE-INDUCING AGENT | 2017 |
|
RU2777992C2 |
HERPES VACCINE | 2019 |
|
RU2731073C1 |
GENETIC CONSTRUCT ADAPTED TO DELIVER THE HUMAN SMN1 GENE WITH ADENO-ASSOCIATED VIRUS OF SEROTYPE 2 TO PROVIDE NEUROSPECIFIC EXPRESSION | 2022 |
|
RU2801848C1 |
METHOD FOR OBTAINING A PREPARATION OF THE RIBONUCLEOPROTEIN COMPLEX CRISPR / Cas14 AND A PREPARATION FOR DETECTING THE RNA OF THE SARS-CoV-2 VIRUS IN ULTRA-LOW CONCENTRATIONS | 2021 |
|
RU2764024C1 |
CRISPR-CAS14 SYSTEM FOR DETECTING SARS-CoV-2 VIRUS RNA AT ULTRA-LOW CONCENTRATIONS | 2021 |
|
RU2764020C1 |
MATERIALS AND METHODS USED FOR TREATMENT OF RESPIRATORY DISEASES IN DOGS | 2020 |
|
RU2811752C2 |
VACCINES AGAINST HPV | 2012 |
|
RU2644201C2 |
Authors
Dates
2018-08-17—Published
2017-05-23—Filed